
Shahnam J. Sharareh
Examiner (ID: 15862)
| Most Active Art Unit | 1617 |
| Art Unit(s) | 1616, 1617, 1619 |
| Total Applications | 311 |
| Issued Applications | 107 |
| Pending Applications | 52 |
| Abandoned Applications | 152 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7467320
[patent_doc_number] => 20040198834
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-07
[patent_title] => 'Concentrated X-ray contrast media can act as universal antigens and can inhibit or prevent allergic reactions'
[patent_app_type] => new
[patent_app_number] => 10/821352
[patent_app_country] => US
[patent_app_date] => 2004-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 6679
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0198/20040198834.pdf
[firstpage_image] =>[orig_patent_app_number] => 10821352
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/821352 | Concentrated X-ray contrast media can act as universal antigens and can inhibit or prevent allergic reactions | Apr 8, 2004 | Issued |
Array
(
[id] => 7200459
[patent_doc_number] => 20050042281
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-24
[patent_title] => 'Compositions for delivering therapeutic agents across the oral mucosa'
[patent_app_type] => utility
[patent_app_number] => 10/646990
[patent_app_country] => US
[patent_app_date] => 2003-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10400
[patent_no_of_claims] => 69
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0042/20050042281.pdf
[firstpage_image] =>[orig_patent_app_number] => 10646990
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/646990 | Compositions for delivering therapeutic agents across the oral mucosa | Aug 20, 2003 | Abandoned |
Array
(
[id] => 7387803
[patent_doc_number] => 20040029961
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-12
[patent_title] => 'Composition for controlling fungal growth'
[patent_app_type] => new
[patent_app_number] => 10/408612
[patent_app_country] => US
[patent_app_date] => 2003-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2237
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20040029961.pdf
[firstpage_image] =>[orig_patent_app_number] => 10408612
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/408612 | Composition for controlling fungal growth | Apr 6, 2003 | Abandoned |
| 10/392752 | Calcium taurate as a dietary supplement | Mar 17, 2003 | Abandoned |
Array
(
[id] => 6847525
[patent_doc_number] => 20030166692
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-04
[patent_title] => 'Composition useful as anticancer drug and radiosensitizer'
[patent_app_type] => new
[patent_app_number] => 10/374561
[patent_app_country] => US
[patent_app_date] => 2003-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3886
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20030166692.pdf
[firstpage_image] =>[orig_patent_app_number] => 10374561
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/374561 | Composition useful as anticancer drug and radiosensitizer | Feb 24, 2003 | Abandoned |
Array
(
[id] => 7136317
[patent_doc_number] => 20040044016
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-04
[patent_title] => 'Antiviral agents'
[patent_app_type] => new
[patent_app_number] => 10/351577
[patent_app_country] => US
[patent_app_date] => 2003-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4380
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0044/20040044016.pdf
[firstpage_image] =>[orig_patent_app_number] => 10351577
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/351577 | Antiviral agents | Jan 26, 2003 | Abandoned |
Array
(
[id] => 6865525
[patent_doc_number] => 20030191051
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-09
[patent_title] => 'Combination therapy for the treatment of bacterial infections'
[patent_app_type] => new
[patent_app_number] => 10/348300
[patent_app_country] => US
[patent_app_date] => 2003-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10958
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20030191051.pdf
[firstpage_image] =>[orig_patent_app_number] => 10348300
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/348300 | Combination therapy for the treatment of bacterial infections | Jan 20, 2003 | Abandoned |
Array
(
[id] => 6729569
[patent_doc_number] => 20030185759
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-02
[patent_title] => 'Ultrasound contrast agents and methods of making and using them'
[patent_app_type] => new
[patent_app_number] => 10/336760
[patent_app_country] => US
[patent_app_date] => 2003-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 23366
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0185/20030185759.pdf
[firstpage_image] =>[orig_patent_app_number] => 10336760
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/336760 | Ultrasound contrast agents and methods of making and using them | Jan 5, 2003 | Abandoned |
Array
(
[id] => 6673769
[patent_doc_number] => 20030059372
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-27
[patent_title] => 'Methods for embolizing vascular sites using high-viscosity embolizing compositions'
[patent_app_type] => new
[patent_app_number] => 10/281156
[patent_app_country] => US
[patent_app_date] => 2002-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6463
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20030059372.pdf
[firstpage_image] =>[orig_patent_app_number] => 10281156
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/281156 | Methods for embolizing vascular sites using high-viscosity embolizing compositions | Oct 27, 2002 | Abandoned |
Array
(
[id] => 6814180
[patent_doc_number] => 20030073730
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-17
[patent_title] => 'Use of amino-isoxazolidone compounds for treatment of memory impairment following traumatic brain injury'
[patent_app_type] => new
[patent_app_number] => 10/271814
[patent_app_country] => US
[patent_app_date] => 2002-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6079
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0073/20030073730.pdf
[firstpage_image] =>[orig_patent_app_number] => 10271814
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/271814 | Use of amino-isoxazolidone compounds for treatment of memory impairment following traumatic brain injury | Oct 15, 2002 | Abandoned |
Array
(
[id] => 6864832
[patent_doc_number] => 20030190358
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-09
[patent_title] => 'Sustained release hydromorphone formulations exhibiting bimodal characteristics'
[patent_app_type] => new
[patent_app_number] => 10/242174
[patent_app_country] => US
[patent_app_date] => 2002-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 22673
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0190/20030190358.pdf
[firstpage_image] =>[orig_patent_app_number] => 10242174
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/242174 | Sustained release hydromorphone formulations exhibiting bimodal characteristics | Sep 11, 2002 | Abandoned |
Array
(
[id] => 7367475
[patent_doc_number] => 20040006048
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-08
[patent_title] => 'Combination of lecithin with ascorbic acid'
[patent_app_type] => new
[patent_app_number] => 10/221043
[patent_app_country] => US
[patent_app_date] => 2002-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3025
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0006/20040006048.pdf
[firstpage_image] =>[orig_patent_app_number] => 10221043
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/221043 | Combination of lecithin with ascorbic acid | Sep 8, 2002 | Abandoned |
Array
(
[id] => 6778135
[patent_doc_number] => 20030049216
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-13
[patent_title] => 'Color cosmetic compositions containing organic oil and silicone mixture'
[patent_app_type] => new
[patent_app_number] => 10/228890
[patent_app_country] => US
[patent_app_date] => 2002-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5706
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0049/20030049216.pdf
[firstpage_image] =>[orig_patent_app_number] => 10228890
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/228890 | Color cosmetic compositions containing organic oil and silicone mixture | Aug 26, 2002 | Abandoned |
Array
(
[id] => 6870538
[patent_doc_number] => 20030083228
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-01
[patent_title] => 'Treatments for female sexual dysfunction and methods for identifying compounds useful for treating female sexual dysfunction'
[patent_app_type] => new
[patent_app_number] => 10/225258
[patent_app_country] => US
[patent_app_date] => 2002-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 28352
[patent_no_of_claims] => 61
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0083/20030083228.pdf
[firstpage_image] =>[orig_patent_app_number] => 10225258
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/225258 | Treatments for female sexual dysfunction and methods for identifying compounds useful for treating female sexual dysfunction | Aug 19, 2002 | Abandoned |
| 10/069928 | Radiopharmaceutical products and their preparation procedure | Aug 15, 2002 | Abandoned |
Array
(
[id] => 6774702
[patent_doc_number] => 20030018040
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-23
[patent_title] => 'Tnf-alpha inhibitors'
[patent_app_type] => new
[patent_app_number] => 10/203292
[patent_app_country] => US
[patent_app_date] => 2002-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3282
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0018/20030018040.pdf
[firstpage_image] =>[orig_patent_app_number] => 10203292
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/203292 | Tnf-alpha inhibitors | Aug 7, 2002 | Abandoned |
Array
(
[id] => 623143
[patent_doc_number] => 07138104
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-11-21
[patent_title] => 'Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent'
[patent_app_type] => utility
[patent_app_number] => 10/213713
[patent_app_country] => US
[patent_app_date] => 2002-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 57672
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 167
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/138/07138104.pdf
[firstpage_image] =>[orig_patent_app_number] => 10213713
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/213713 | Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent | Aug 6, 2002 | Issued |
Array
(
[id] => 6735100
[patent_doc_number] => 20030012735
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-16
[patent_title] => 'Methods for diagnostic imaging by regulating the administration rate of contrast agent'
[patent_app_type] => new
[patent_app_number] => 10/213533
[patent_app_country] => US
[patent_app_date] => 2002-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 30686
[patent_no_of_claims] => 173
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0012/20030012735.pdf
[firstpage_image] =>[orig_patent_app_number] => 10213533
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/213533 | Methods for diagnostic imaging by regulating the administration rate of contrast agent | Aug 5, 2002 | Abandoned |
Array
(
[id] => 6755278
[patent_doc_number] => 20030003055
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-02
[patent_title] => 'Methods of preparing gaseous precursor-filled microspheres'
[patent_app_type] => new
[patent_app_number] => 10/213600
[patent_app_country] => US
[patent_app_date] => 2002-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 26307
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20030003055.pdf
[firstpage_image] =>[orig_patent_app_number] => 10213600
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/213600 | Methods of preparing gaseous precursor-filled microspheres | Aug 5, 2002 | Abandoned |
Array
(
[id] => 6839227
[patent_doc_number] => 20030036567
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-20
[patent_title] => ' PROPYLENE GLYCOL AS AN AGENT TO STIMUATE THROMBOPOIESIS\n '
[patent_app_type] => original-publication-amended
[patent_app_number] => 10/210854
[patent_app_country] => US
[patent_app_date] => 2002-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4665
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0036/20030036567.pdf
[firstpage_image] =>[orig_patent_app_number] => 10210854
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/210854 | PROPYLENE GLYCOL AS AN AGENT TO STIMUATE THROMBOPOIESISn | Jul 30, 2002 | Abandoned |